Please log in to see the full text of this API!
Omeprazole
-
Synonyms:
H-168/68
-
ATC:
A02BD01
-
Use:
Lorem
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:345.42 g/mol
-
CAS-RN:73590-58-6
-
InChI Key:SUBDBMMJDZJVOS-UHFFFAOYSA-N
-
InChI:InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)
-
LD50:82.8 mg/kg (M, i.v.); >4 g/kg (M, p.o.);
>50 mg/kg (R, i.v.); 2210 mg/kg (R, p.o.)
Derivatives
monosodium salt
-
Use:
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:367.41 g/mol
-
CAS-RN:95510-70-6
-
LD50:278 mg/kg (R, i.v.)
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
108-24-7 |
C4H6O3 |
acetic anhydride |
Acetic acid, anhydride |
84006-10-0 |
C9H12ClNO |
2-(chloromethyl)-3,5-dimethyl-4-methoxypyridine |
Pyridine, 2-(chloromethyl)-4-methoxy-3,5-dimethyl- |
86604-78-6 |
C9H13NO2 |
2-(hydroxymethyl)-3,5-dimethyl-4-methoxypyridine |
2-Pyridinemethanol, 4-methoxy-3,5-dimethyl- |
67-56-1 |
CH4O |
methanol |
Methanol |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
D |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem ipsum |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem ipsum dolor |
|
|
F |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
GB |
Lorem |
Lorem
|
|
Lorem |
|
|
I |
Lorem |
Lorem
|
|
Lorem |
Lorem
,1990 |
|
Lorem |
Lorem
|
|
J |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
USA |
Lorem |
Lorem
|
|
Lorem ipsum |
Lorem
|
|
Lorem |
Lorem
|
|
(wfm = withdrawn from market)
Formulations
- Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumyeirmodtemporinviduntut
References
-
- EP 9 999 (Hässle; appl. 3.4.1979; S-prior. 14.4.1978).
- US 9 999 999 (Hässle; 10.3.1981; S-prior. 14.4.1978).
- US 9 999 999 (Hässle; 2.4.1985; S-prior. 14.4.1978).
-
alternative synthesis of III:
- EP 999 999 (Hässle; appl. 30.6.1983; S-prior. 26.8.1982).
-
alternative synthesis of omeprazole:
- WO 9 999 999 (Slovakofarma; 13.3.1998; appl. 8.9.1997; SK-prior. 9.9.1996).
- WO 9 999 999 (PDI Res.; 14.8.1994; appl. 5.2.1997; CA-prior. 6.2.1996, 10.4.1996).
- WO 9 999 999 (Astra; 26.6.1997; appl. 5.12.1996; S-prior. 15.12.1995).
- US 9 999 999 (Torcan; 20.12.1994; appl. 4.11.1993).
- EP 999 999 (Merck & Co.; 24.3.1993; appl. 12.9.1992; USA-prior. 20.9.1991, 15.10.1991).
- WO 9 999 999 (Astra; 12.12.1991; appl. 5.6.1991; S-prior. 7.6.1990).
- EP 999 999 (Centro Genesis para la Inv.; appl. 24.10.1991; E-prior. 31.10.1990).
- WO 9 999 999 (PDI Research; appl. 21.4.1998; CA-prior. 6.5.1997).
- WO 9 999 999 (Bristol-Myers Squibb; appl. 16.2.1998; DK-prior. 7.3.1997).
- WO 9 999 999 (Knoll AG; appl. 11.3.1999; GB-prior. 17.3.1998).
- EP 999 999 (Takeda Chem. Ind.; appl. 3.8.1988; J-prior. 4.8.1987).
- US 9 999 999 (Merck & Co.).
- US 9 999 999 (Wockhardt Europe Ltd.; 12.6.2001; appl. 30.6.1999).
-
synthesis of intermediates:
- EP 999 999 (Hässle; appl. 8.9.1986; S-prior. 24.9.1985).
- ES 9 999 999 (Centro Genesis; 16.4.1993; appl. 5.4.1991).
-
alkaline salts:
- EP 999 999 (Hässle; appl. 28.2.1984; S-prior. 4.3.1983).
- ES 9 999 999 (Centro Genesis; 1.2.1992).
- WO 9 999 999 (Astra; appl. 11.6.1998; S-prior. 27.6.1997).
-
cyclodextrin complexes:
- EP 999 999 (Byk Gulden Lomberg; appl. 24.7.1985; D-prior. 27.7.1984).
-
oral composition:
- US 9 999 999 (Hässle; 22.11.1988; GB-prior. 30.4.1986).
- EP 999 999 (Yoshitomi; appl. 16.4.1987; GB-prior. 30.4.1986).
- WO 9 999 999 (Astra; 25.1.1996; appl. 7.6.1995; S-prior. 8.7.1994).
- US 9 999 999 (Esteve; 3.8.1993; E-prior. 31.12.1990, 24.6.1991).
- WO 9 999 999 (Sage Pharm; appl. 8.5.1998; USA-prior. 9.5.1997; 15.10.1997).
-
new crystalline form of omeprazole:
- WO 9 999 999 (Astra; appl. 10.11.1998).
-
transdermal application:
- WO 9 999 999 (Upjohn; appl. 1.5.1989; USA-prior. 30.6.1988).
-
treatment of osteoporosis:
- EP 999 999 (Hässle; appl. 27.10.1988; S-prior. 30.10.1987).